|Articles|May 22, 2018
Saama Technologies and ICON Partner to Unlock the Value of RWE
Advertisement
Saama Technologies, a clinical and health data analytics company, and ICON plc, a global provider of drug development and commercialization solutions and services, have partnered to accelerate the use of Real World Evidence across the product lifecycle and drive mission critical decisions for medical affairs, reimbursement, and commercialization functions.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What It Actually Means to Embed the Patient Voice in Trial Design
2
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
3
ACT Brief: Explainable AI for Patient Subgroups, Participant Understanding and Engagement, and FDA Leadership Stabilization
4
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
5